Search Results for: stem cells for ms

Weekly reads: ‘junk DNA’, COVID chaos, CRISPR CasΦ, & postdoc opps, more

/ / 2 Comments
Retroviral-genes-Junk-DNA-NIHsmall

Here are our weekly recommended regenerative medicine and other notable science reads including a few things on COVID. It’s been quite an interesting week. “Junk DNA” is not so junky, role in differentiation NIH scientists showed how ancient retroviral genes, or “junk DNA”, may play a role in helping stem cells decide to become neurons. This […]

Weekly reads: ‘junk DNA’, COVID chaos, CRISPR CasΦ, & postdoc opps, more Read More »

OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads

/ / 1 Comment
EMBO-J-2020-Fig-3b-Salazar-Roa-et-al

What’s new in the stem cell, cell therapy, and regenerative medicine world as well as biomedical science more generally including cancer? There’s quite a bit of news as reflected in media pieces and new pubs. Today’s post is focused on pubs that just came out. For last week’s recommended reads see here. Oct4-Sox2 Nucleosome Binding

OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads Read More »

Weekly reads: organoids, COVID-19, CIRM & cool new pubs

/ / Leave a Comment
Human-intestinal-organoids-infected-with-SARS-CoV-2-white.-Credit-Joep-BeumerClevers-groupHubrecht-Institute

Organoids are providing a novel avenue into the pathogenesis of COVID-19 and novel models for drug screening. A number of new preprints on respiratory organoids shed new light in this area. They were highlighted in a Nature newsy piece, Mini organs reveal how the coronavirus ravages the body. It’s a challenge to study COVID-19 infections because just infecting

Weekly reads: organoids, COVID-19, CIRM & cool new pubs Read More »

Striking FDA Hahn & Marks JAMA pub on regenerative clinics

/ / 5 Comments
Dr-Stephen-Hahn-Commissioner-of-FDA

It was fascinating to read a new JAMA piece by the FDA on unproven stem cell clinics and other regenerative medicine firms. Many of these guys are profiteering off of buzz about exciting, but mostly unproven technologies. While the JAMA opinion piece reiterates the agency’s commitment to evidence-based regenerative medicine, it also makes some other

Striking FDA Hahn & Marks JAMA pub on regenerative clinics Read More »

Duke Autism Center trial: no benefit of cord blood for autism

/ / 12 Comments
stem cells for autism

A solid new, blinded placebo-controlled Phase II study from the Duke Autism Center clearly shows no benefit of cord blood for autism. Surprisingly, the team has said they are encouraged by the results. As a result, they apparently will continue this kind of work anyway despite their data. In contrast, I see the data as a

Duke Autism Center trial: no benefit of cord blood for autism Read More »